Virbac SA (VIRP) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.023x

Based on the latest financial reports, Virbac SA (VIRP) has a cash flow conversion efficiency ratio of 0.023x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€24.89 Million ≈ $29.09 Million USD) by net assets (€1.07 Billion ≈ $1.25 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see VIRP stock market capitalisation for the company's overall valuation and market capitalisation.

Virbac SA - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Virbac SA's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Virbac SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Virbac SA ranked by their cash flow conversion efficiency. Explore cash flow quality index of Virbac SA to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	0.021x
Brederode SA BR:BREB	0.000x
AIR CHINA LTD H ADR/20 F:AD2B	N/A
Becle S.A.B. de C.V MX:CUERVO	0.026x
Vidrala SA MC:VID	0.048x
Red Rock Resorts Inc NASDAQ:RRR	0.541x
Schneider National Inc NYSE:SNDR	0.056x
Provident Financial Services Inc NYSE:PFS	0.041x

Annual Cash Flow Conversion Efficiency for Virbac SA (2002–2024)

The table below shows the annual cash flow conversion efficiency of Virbac SA from 2002 to 2024. View VIRP stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€1.04 Billion ≈ $1.22 Billion	€204.22 Million ≈ $238.76 Million	0.196x	+49.71%
2023-12-31	€909.92 Million ≈ $1.06 Billion	€118.96 Million ≈ $139.07 Million	0.131x	+10.81%
2022-12-31	€838.98 Million ≈ $980.86 Million	€98.98 Million ≈ $115.72 Million	0.118x	-34.14%
2021-12-31	€725.19 Million ≈ $847.82 Million	€129.90 Million ≈ $151.87 Million	0.179x	-1.30%
2020-12-31	€655.22 Million ≈ $766.02 Million	€118.92 Million ≈ $139.03 Million	0.181x	-23.89%
2019-12-31	€551.88 Million ≈ $645.20 Million	€131.61 Million ≈ $153.86 Million	0.238x	+41.41%
2018-12-31	€495.87 Million ≈ $579.73 Million	€83.62 Million ≈ $97.76 Million	0.169x	-25.10%
2017-12-31	€478.82 Million ≈ $559.79 Million	€107.81 Million ≈ $126.04 Million	0.225x	-17.69%
2016-12-31	€520.79 Million ≈ $608.85 Million	€142.45 Million ≈ $166.54 Million	0.274x	+185.41%
2015-12-31	€482.29 Million ≈ $563.85 Million	€46.22 Million ≈ $54.04 Million	0.096x	-39.55%
2014-12-31	€482.19 Million ≈ $563.73 Million	€76.45 Million ≈ $89.37 Million	0.159x	-10.78%
2013-12-31	€414.37 Million ≈ $484.45 Million	€73.63 Million ≈ $86.08 Million	0.178x	-27.04%
2012-12-31	€398.42 Million ≈ $465.79 Million	€97.03 Million ≈ $113.44 Million	0.244x	+23.73%
2011-12-31	€313.87 Million ≈ $366.94 Million	€61.78 Million ≈ $72.23 Million	0.197x	-29.06%
2010-12-31	€302.35 Million ≈ $353.48 Million	€83.90 Million ≈ $98.08 Million	0.277x	+1.18%
2009-12-31	€236.20 Million ≈ $276.14 Million	€64.78 Million ≈ $75.73 Million	0.274x	+30.39%
2008-12-31	€201.01 Million ≈ $235.01 Million	€42.28 Million ≈ $49.43 Million	0.210x	-23.17%
2007-12-31	€184.28 Million ≈ $215.45 Million	€50.45 Million ≈ $58.98 Million	0.274x	-7.49%
2006-12-31	€164.93 Million ≈ $192.82 Million	€48.81 Million ≈ $57.06 Million	0.296x	+32.55%
2005-12-31	€160.19 Million ≈ $187.28 Million	€35.76 Million ≈ $41.81 Million	0.223x	-29.10%
2004-12-31	€131.17 Million ≈ $153.35 Million	€41.30 Million ≈ $48.29 Million	0.315x	+52.97%
2003-12-31	€129.09 Million ≈ $150.91 Million	€26.57 Million ≈ $31.07 Million	0.206x	-11.79%
2002-12-31	€132.52 Million ≈ $154.93 Million	€30.92 Million ≈ $36.15 Million	0.233x	--

About Virbac SA

PA:VIRP France Drug Manufacturers - General

Market Cap

$3.04 Billion

€2.60 Billion EUR

Market Cap Rank

#4935 Global

#83 in France

Share Price

€310.50

Change (1 day)

-1.27%

52-Week Range

€302.00 - €384.00

All Time High

€437.64